

<!-- page 1 -->

wxl 2110$2  - 2019 fmnrjdß ui 11 jeks i÷od - 2019'02'11
^rcfha n,hmsg m%isoaO lrk ,§)
I jeks fldgi: (I) jeks fPoh - idudkH
rcfha ksfõok
2013 wxl 33 ork l%Svdj, fh§fï § W;af;acl øjH .ekSug tfrys iïuq;s mk;
2013 wxl 33 ork l%Svdj, fh§fï § W;af;acl øjH .ekSug tfrys iïuq;s mkf;a 3 jeks j.ka;sh iu. lshúh hq;= 34 jeks
j.ka;sh hgf;a l%Svd wud;Hjrhd úiska idok ,o ksfhda.'
yÍka m%kdkaÿ"
úÿ,s ixfoaY" úfoaY /lshd yd l%Svd wud;H'
2019 ckjdß ui 25 jeks Èk"
fld<U § h'
ksfhda.
1' fuu ksfhda. 2018 wxl 04 ork ;ykï W;af;acl ^;ykï lrk ,o ,ehsia;=j& ksfhda. hkqfjka y÷kajkq ,efí'
2' fuu ksfhda. 2019 ckjdß ui 01 jeks Èk isg l%shd;aul jk f,i ie,lsh hq;= h'
f,dal ;ykï W;af;acl øjHhka ms<sn| kS;s ix.%yh
;ykï øjH ,ehsia;=j 2019
wka;¾ cd;sl m%ñ;sh
;ykï øjH ,ehsia;=j ms<sn| fuu ks, ,shú,a, f,dal W;af;acl u¾ok ksfhdacHdh;kh úiska mj;ajdf.k hd
hq;= w;r bx.%Sis iy m%xY NdIdj,ska m%ldYhg m;a l< hq;= h' bx.%Sis iy m%xY wkqjdohka w;r hïlsis >Ügkhla we;sjk
wjia:djl" bx.%Sis wkqjdoh n, meje;aúh hq;= h'
fuu ,ehsia;=j 2019 ckjdß ui 01 Èk isg n, meje;aúh hq;=h'
;ykï øjH ,ehsia;=j 2019
2018 iema;eïn¾
Y%S ,xld m%cd;dka;%sl iudcjd§ ckrcfha .eiÜ m;%h
w;s úfYI
 1A - G 28939 —   107  (2019/01)
 fuu w;s úfYI .eiÜ m;%h  www.documents.gov.lk fjí wvúfhka nd.; l< yel'
                  
       
              
               
            
        
                  
     
         
             
         
               
            
               
               
            
               
        
                 
        
              
               
            
         
                  

<!-- page 2 -->

2  A I  fldgi: (I) fPoh - Y%S ,xld m%cd;dka;%sl iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2019'02'11
f,dal ;ykï W;af;acl øjHhka ms<sn| kS;s ix.%yh
;ykï øjH ,ehsia;=j 2019
ish¨ wjia:djka ys § ;ykï øjHhka yd l%u
^;r.j, § yd bka msg; §&
f,dal ;ykï W;af;acl øjHhka ms<sn| kS;s ix.%yfha 4'2'2 j.ka;sh m%ldrj" S1" S2" S4'4" S4'5" S6'A mka;sj, olajd
we;s øjHhka iy M1" M2 iy M3 ys olajd we;s ;ykï lrk ,o l%u yer ish¨ ;ykï øjHhka —úfYaIs; øjHhka˜ f,i i,lkq
,eìh hq;=h'
;ykï lrk ,o øjHhka
SO' wkqu; lr fkdue;s øjHhka
,ehsia;=fõ miqj tk j.ka;s lsisjla u.ska y÷kajd § fkdue;s iy udkj Ñls;ail Ndú;h i|yd hï rdcH fi!LH kshduk
wêldßhla úiska oekg wkque;sh ,nd § fkdue;s ^mQ¾j-idhk fyda idhksl ixj¾Okh hgf;a jQ fyda w;aysgqjk ,o T!IO"
ks¾udKl T!IO" i;a;aj frda. i|yd muKla wkqu; øjHhka& fï T!IOfõ§ øjHhka ish¿ wjia:djka ys § ;ykï lrkq ,en
we;'
S1' wekfnd,sla ldrl
wekfnd,sla ldrl ;ykï lrkq ,en we;'
1' wekfnd,sla wekafv%dfcksla iafgfrdhsâia
w' nys¾ckH  we;=¿j (
1-wekafv%diaafgksäfhda,a1-wekafv%diaafgksäfhda,a1-wekafv%diaafgksäfhda,a1-wekafv%diaafgksäfhda,a1-wekafv%diaafgksäfhda,a  ^5 -androst-1-ene-3 17-diol& · 1-wekafv%diafgksäfhdaka1-wekafv%diafgksäfhdaka1-wekafv%diafgksäfhdaka1-wekafv%diafgksäfhdaka1-wekafv%diafgksäfhdaka      (5-androst-1-ene-3,17-dione)
11111 wekafv%diafgfrdakawekafv%diafgfrdakawekafv%diafgfrdakawekafv%diafgfrdakawekafv%diafgfrdaka      (3hydroxy-5-androst-1-ene-17-one) · · · · · fnd,eiafgfrdakafnd,eiafgfrdakafnd,eiafgfrdakafnd,eiafgfrdakafnd,eiafgfrdaka  ·  ·  ·  ·  · le,iaffrdakale,iaffrdakale,iaffrdakale,iaffrdakale,iaffrdaka  ·  ·  ·  ·  · laf,diagfnda,laf,diagfnda,laf,diagfnda,laf,diagfnda,laf,diagfnda, AAAAA
· · · · · vekfida,avekfida,avekfida,a
vekfida,avekfida,a     ([1,2]oxazolo[4',5':2,3]pregna-4-en-20-yn-17 -ol) · · · · · äyhsfv%dlaf,da¾fu;s,afgiafgdiafgfrdakaäyhsfv%dlaf,da¾fu;s,afgiafgdiafgfrdakaäyhsfv%dlaf,da¾fu;s,afgiafgdiafgfrdakaäyhsfv%dlaf,da¾fu;s,afgiafgdiafgfrdakaäyhsfv%dlaf,da¾fu;s,afgiafgdiafgfrdaka      (4-chloro-
17-hydroxy-17-methylandrosta-1,4-dien-3-one)  ·  ·  ·  ·  · äfidlaisfu;s,afgiafgdiafgfrdakaäfidlaisfu;s,afgiafgdiafgfrdakaäfidlaisfu;s,afgiafgdiafgfrdakaäfidlaisfu;s,afgiafgdiafgfrdakaäfidlaisfu;s,afgiafgdiafgfrdaka      (17-methyl-5-androst-2-en-
17-ol iyiyiyiyiy (17-methyl-5-androst-3-en-17-ol)· · · · · fv%diagefkdf,dakafv%diagefkdf,dakafv%diagefkdf,dakafv%diagefkdf,dakafv%diagefkdf,daka  ·  ·  ·  ·  · t;s,aBiag%fkda,at;s,aBiag%fkda,at;s,aBiag%fkda,at;s,aBiag%fkda,at;s,aBiag%fkda,a      (19-norpregna-4-en-17 -ol) ·····
*aÆTlaisfuiafgfrdaka*aÆTlaisfuiafgfrdaka*aÆTlaisfuiafgfrdaka*aÆTlaisfuiafgfrdaka*aÆTlaisfuiafgfrdaka  ·  ·  ·  ·  · f*da¾fufndf,dakf*da¾fufndf,dakf*da¾fufndf,dakf*da¾fufndf,dakf*da¾fufndf,daka · a · a · a · a · *shqrifnda,a*shqrifnda,a*shqrifnda,a*shqrifnda,a*shqrifnda,a     (17-methyl [1,2,5] oxadiazolo[3',4',:2,3]-5 -androstan-17-
ol) · · · · · fciaá%fkdakafciaá%fkdakafciaá%fkdakafciaá%fkdakafciaá%fkdaka  · · · · · fuiagfkdf,dakafuiagfkdf,dakafuiagfkdf,dakafuiagfkdf,dakafuiagfkdf,daka  ·  ·  ·  ·  · fuiagfrdf,dakafuiagfrdf,dakafuiagfrdf,dakafuiagfrdf,dakafuiagfrdf,daka  ·  ·  ·  ·  · fugkaäfkdakafugkaäfkdakafugkaäfkdakafugkaäfkdakafugkaäfkdaka      (17-hydroxy-17 -methylandrosta-1,4-
dien-3-one) · · · · · fugfkdf,dakafugfkdf,dakafugfkdf,dakafugfkdf,dakafugfkdf,daka ·  ·  ·  ·  · fu;kaä%fhda,afu;kaä%fhda,afu;kaä%fhda,afu;kaä%fhda,afu;kaä%fhda,a ·  ·  ·  ·  · fu;iafgfrdakafu;iafgfrdakafu;iafgfrdakafu;iafgfrdakafu;iafgfrdaka     (17-hydroxy-2,17-dimethyl-5-androstan-3-one)
· · · · · fu;s,aähfkdf,dakafu;s,aähfkdf,dakafu;s,aähfkdf,dakafu;s,aähfkdf,dakafu;s,aähfkdf,daka      (17-hydroxy-17-methylestra-4,9-dien-3-one)  ·  ·  ·  ·  · fu;s,a-1-fgiafgdiafgfrdakafu;s,a-1-fgiafgdiafgfrdakafu;s,a-1-fgiafgdiafgfrdakafu;s,a-1-fgiafgdiafgfrdakafu;s,a-1-fgiafgdiafgfrdaka      (17-hydroxy-
17-methyl-5 -androst-1-en-3-one)  ·  ·  ·  ·  · fu;s,afkda¾fgiafgdiafgfrdakafu;s,afkda¾fgiafgdiafgfrdakafu;s,afkda¾fgiafgdiafgfrdakafu;s,afkda¾fgiafgdiafgfrdakafu;s,afkda¾fgiafgdiafgfrdaka      (17-hydroxy-17 -methylestr-4-en-3-one)
·····fu;s,afgiafgdiafgfrdakafu;s,afgiafgdiafgfrdakafu;s,afgiafgdiafgfrdakafu;s,afgiafgdiafgfrdakafu;s,afgiafgdiafgfrdaka  ·  ·  ·  ·  · fuá%fndaf,dakafuá%fndaf,dakafuá%fndaf,dakafuá%fndaf,dakafuá%fndaf,daka      (methyltrienolone,17 -hydroxy-17 -methylestra-4,9,11-trien-3-one)  · · · · ·
ñfndf,frdakañfndf,frdakañfndf,frdakañfndf,frdakañfndf,frdaka  ·  ·  ·  ·  · fkda¾fndf,fgdakafkda¾fndf,fgdakafkda¾fndf,fgdakafkda¾fndf,fgdakafkda¾fndf,fgdaka  ·  ·  ·  ·  · fkda¾laf,diafgfnda,afkda¾laf,diafgfnda,afkda¾laf,diafgfnda,afkda¾laf,diafgfnda,afkda¾laf,diafgfnda,a  ·  ·  ·  ·  · fkdarss;ekafv%df,dakafkdarss;ekafv%df,dakafkdarss;ekafv%df,dakafkdarss;ekafv%df,dakafkdarss;ekafv%df,daka  ·  ·  ·  ·  · Tlaifndaf,dakaTlaifndaf,dakaTlaifndaf,dakaTlaifndaf,dakaTlaifndaf,daka  · · · · ·
Tlaiekafv%df,dakaTlaiekafv%df,dakaTlaiekafv%df,dakaTlaiekafv%df,dakaTlaiekafv%df,daka  ·  ·  ·  ·  · Tlaisfuiagfrdaka Tlaisfuiagfrdaka Tlaisfuiagfrdaka Tlaisfuiagfrdaka Tlaisfuiagfrdaka · · · · · Tlaisfu;f,dakaTlaisfu;f,dakaTlaisfu;f,dakaTlaisfu;f,dakaTlaisfu;f,daka  ·  ·  ·  ·  · fm%diagefkdfida,afm%diagefkdfida,afm%diagefkdfida,afm%diagefkdfida,afm%diagefkdfida,a      (17-[(tetrahydropyran-2-yl) oxy]-1'
H-pirazolo[3,4;2,3]-5-androstane) :      l=hskafndaf,dakal=hskafndaf,dakal=hskafndaf,dakal=hskafndaf,dakal=hskafndaf,daka  ·  ·  ·  ·  · iagefkdfidf,da,aiagefkdfidf,da,aiagefkdfidf,da,aiagefkdfidf,da,aiagefkdfidf,da,a ·  ·  ·  ·  · iafgkafndaf,dakaiafgkafndaf,dakaiafgkafndaf,dakaiafgkafndaf,dakaiafgkafndaf,daka  ·  ·  ·  ·  · 1-fgiafgdiafgfrdaka1-fgiafgdiafgfrdaka1-fgiafgdiafgfrdaka1-fgiafgdiafgfrdaka1-fgiafgdiafgfrdaka
(17-hydroxy-5-androst-1-en-3-one)· · · · · fgg%dyhsfv%dfciaá%fkdakafgg%dyhsfv%dfciaá%fkdakafgg%dyhsfv%dfciaá%fkdakafgg%dyhsfv%dfciaá%fkdakafgg%dyhsfv%dfciaá%fkdaka     (17-hydroxy-18 a-homo-19-nor-17-pregna-4,9,11-trien-
3-one) ( fg%kafndaf,daka( fg%kafndaf,daka( fg%kafndaf,daka( fg%kafndaf,daka( fg%kafndaf,daka      (17-hydroxyestr-4,9,11-trien-3-one)      iy iudk ridhksl jHQyhla fyda iudk cSj úoHd;aul
n,mEula ^n,mEï& we;s fjk;a øjHhka'
wd' wNHka;rfhka yg.; wNHka;rfhka yg.; wNHka;rfhka yg.; wNHka;rfhka yg.; wNHka;rfhka yg.; a a a a a ***AAS     nys¾ckH f,i foay.; lrk úg '
4 - wekafv%diafgfkäfhd,a ^4 - wekafv%diafgfkäfhd,a ^4 - wekafv%diafgfkäfhd,a ^4 - wekafv%diafgfkäfhd,a ^4 - wekafv%diafgfkäfhd,a ^ androst-4-ene-3,17-diol& & & & & ····· 4 - yhsfv%dlaisfgiafgdiafgfrdaka ^ 4 - yhsfv%dlaisfgiafgdiafgfrdaka ^ 4 - yhsfv%dlaisfgiafgdiafgfrdaka ^ 4 - yhsfv%dlaisfgiafgdiafgfrdaka ^ 4 - yhsfv%dlaisfgiafgdiafgfrdaka ^ 4-17-dihydroxyandrost-
-4-en-3one& & & & & · · · · · 5 - wekafv%diafgfkäfhdaka ^5 - wekafv%diafgfkäfhdaka ^5 - wekafv%diafgfkäfhdaka ^5 - wekafv%diafgfkäfhdaka ^5 - wekafv%diafgfkäfhdaka ^ androst-5-ene-3, 17 dione& & & & & · · · · · 7-hydroxy-DHEA ; 7 -hydroxy-DHEA, 7-
keto-DHEA ;
19 - fkd/kafv%diafgksäfhda,a ^19 - fkd/kafv%diafgksäfhda,a ^19 - fkd/kafv%diafgksäfhda,a ^19 - fkd/kafv%diafgksäfhda,a ^19 - fkd/kafv%diafgksäfhda,a ^ estr-4-ene-3,17-diol & ( 19-fkd/kafv%diafgksäfhdaka & ( 19-fkd/kafv%diafgksäfhdaka & ( 19-fkd/kafv%diafgksäfhdaka & ( 19-fkd/kafv%diafgksäfhdaka & ( 19-fkd/kafv%diafgksäfhdaka (estr - 4 - ene - 3, 17 dione) ·····
wekafv%diafgkf,daka ^wekafv%diafgkf,daka ^wekafv%diafgkf,daka ^wekafv%diafgkf,daka ^wekafv%diafgkf,daka ^ 5-dihydrotestosterone, 17 -hydroxy-5-androstan-3-one & wekafv%diafgäfhda,a ^& wekafv%diafgäfhda,a ^& wekafv%diafgäfhda,a ^& wekafv%diafgäfhda,a ^& wekafv%diafgäfhda,a ^ androst-5-ene-
3,17-diol& wekafv%diafgksäfhdka ^& wekafv%diafgksäfhdka ^& wekafv%diafgksäfhdka ^& wekafv%diafgksäfhdka ^& wekafv%diafgksäfhdka ^ androst-4-ene-3,17-dione & fnda,aäfkdaka( fnda,aäfhdaka & fnda,aäfkdaka( fnda,aäfhdaka & fnda,aäfkdaka( fnda,aäfhdaka & fnda,aäfkdaka( fnda,aäfhdaka & fnda,aäfkdaka( fnda,aäfhdaka (androsta - 1,4-diene-3,
17-dione) ( tmswekafv%iafgfrdka ( tmsvhsyhsfv%dfgiafgdiafgfrdaka ( tmswekafv%iafgfrdka ( tmsvhsyhsfv%dfgiafgdiafgfrdaka ( tmswekafv%iafgfrdka ( tmsvhsyhsfv%dfgiafgdiafgfrdaka ( tmswekafv%iafgfrdka ( tmsvhsyhsfv%dfgiafgdiafgfrdaka ( tmswekafv%iafgfrdka ( tmsvhsyhsfv%dfgiafgdiafgfrdaka (3-hydroxy-5a-androstan-17-one) ·····     (17-hydroxy-
5-androstan-3 -one) · · · · · tmsfgiafgdiafgfrdka tmsfgiafgdiafgfrdka tmsfgiafgdiafgfrdka tmsfgiafgdiafgfrdka tmsfgiafgdiafgfrdka · · · · · kekafv%df,dakakekafv%df,dakakekafv%df,dakakekafv%df,dakakekafv%df,daka      (19-nortestrosterone) · · · · · m%eiafgfrdakam%eiafgfrdakam%eiafgfrdakam%eiafgfrdakam%eiafgfrdaka
(dehydroepiandrosterone, DHEA, 3 -hydroxyandrost-5-en-17-one) · · · · · fgiafgdiafgfrdaka fgiafgdiafgfrdaka fgiafgdiafgfrdaka fgiafgdiafgfrdaka fgiafgdiafgfrdaka ·····

<!-- page 3 -->

I fldgi: (I) fPoh - Y%S ,xld m%cd;dka;%sl iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h -  2019'02'11 3 A
iy tajdfha we;=<;A mrsjD;a;Sh l%shd i|yd wjYH øjHhka iy iudjhúlhka we;=,;a úh hq;= kuq;a my; øjHhkAg iSud fkdúh
hq;=h ·
2' fjk;a wekfnd,sla ldrl'
my; i|yka fjk;a wekfnd,sla ldrl we;=<;a úh hq;= kuq;a" tajdg iSud fkdúh hq;=hs'
laf,kaìhqgfrda,a" f;dard.;a wekafv%dcka ßfimag¾ fudähqf,ag¾ ^SARMs ; 
Wod' wekavßka" LGD - 4033, tfkdfndidï ^Tiagßka&
iy  RAD140&" ánf,daka" firfkda,a iy is,amfgfrda,a"
 fï j.ka;sfha ld¾hhka i|yd (
  *‘‘nys¾ckH ^exogenous&˜ hkakg YÍrfhka idudkHfhka ksmoúh fkdyels øjHhka woyia fõ'
  *‘‘wNHka;rfhka yg.;a ^endogenous&˜ hkakg" YÍrfhka iajNdúlju ksmoúh yels øjHhka woyia fõ'
S2' fmmaghsâ fyda¾fudak" j¾Ol øjH idOl ^Growth Factors& wdY%s; øjH yd wkqldrl
my; oelafjk øjHhka iy iudk ridhksl jHqyhka fyda iudk Ôj úoHd;aul n,mEula ^n,mEï& we;s fjk;a øjHhka" ;ykï fõ'
 1' tßf;%dfmdfhàka ^EPO& iy tßf;%dfmdfhisia l%shdj,shg n,mEï we;s l< yels ldrl we;=<;a úh hq;= kuq;a" tjdg iSud
fkdúh hq;= h'
1'1 tßf;%dfmdfháka - m%;s.%dyl we.ksiaáia
Wod'  vdnfmdfhàka ^dEPO& ( tßf;%dfmdfháka (EPO) : EPO - mokï jQ jHqyhka ^EPO-Fc,  ñf;dlais fmd,st;s,Ska
.a,hsflda,a - tfmdfhàka îgd ^CERA& ( EPO uhsueála ldrl yd tys jHqyhka ^Wod' CNTO - 530 iy fm.sfkighsâ& (
1'2 yhsfmdlaishd - bkaähqisn,a *elag¾ (HIF)" ia:dhsldrl' Wod( wd.ka" fldafnda,aÜ" vemafrdvqiageÜ ^GSK 1278863& (
fud,svqiageÜ ^BAY 85-3934&"  frdlaivqiageÜ ^FG - 4592&" jvdvqiageÜ ^AKB-6548&"  fifkdaka (
1'3 GATA ksfIaOl Wod ( K-11706
1'4 TGF - îgd ^TGF - & ksfIaOl" Wod' ¨iameg¾fimaÜ" fidgeg¾fimaÜ
1'5 bfkÜ ßfmhd ßfimag¾ we.ksiaÜ - tAishdf,da EPO ( ldnuhsf,agâ  EPO (CEPO)
2' fmmaghsv fydafudak iy bka uqÞ yßk øjHhka (
2'1 fldßfhdaksla f.dkefvdfg%da*ska ^CG& iy mqreIhkaf.a ¨ákhsiSka fydafudak ^LH& iy bka uqÞ yßk øjHhka ( Wo (
ìhqfiß,Ska" fviaf,dfr,ska" f.dkfvdfr,ska" f.diafr,ska" ,shqfm%dfr,ska" kef*r,Ska iy á%mafgdfr,Ska'
2'2 fldaáfldaÜfrd*skaia iy bka uqÞ yßk øjHka" Wod' ( fldaáfldfr,ska (
2'3 j¾Ol fydafudak ^ GH& tAjdfha fldgia iy tAjdhska uqÞyßk øjHhka we;=<;a úh hq;= kuq;a tAjdg iSud fkdúh
hq;= hs'
j¾Ol fydafudak fldgia ( Wod' AOD - 9604 iy HGH 176-191
j¾Ol fydafudak ^GHRH& iy tAjdfha iuldrl Wod' ( CJC-1293, CJC-1295, i¾fudfr,ska iy fgifudfr,ska (

<!-- page 4 -->

4  A I  fldgi: (I) fPoh - Y%S ,xld m%cd;dka;%sl iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2019'02'11
j¾Ol fydafudak fil%gf.da.aia ^GHS& Wod ( f,kfudfr,ska ^f.%,ska& iy wkqldrl" Wod' ( wekfudfr,Ska" bmfudafr,Ska (
ueisfudfr,Ska iy geìfudr,Ska ( GH - uqodyßk fmmaghsâia ^GHRPs& Wod' ( wef,laiefudfr,Ska" GHRP-1, GHRP-2 ^m%e,afudfr,Ska&"
GHRP-3, GHRP-4, GHRP-5, GHRP-6 iy tlaifudfr,Ska ^fylair,Ska&
3' j¾Ol fydafudak iy j¾Ol fydafudak fudähqf,ag¾ we;=<;a úh hq;= kuq;a tAjdg iSud fkdúh hq;= h'
*hsfn%dí,diaÜ j¾Ol øjH ^FGFs& ( fymfgdihsÜ j¾Ol øjH ^HGF& ( bksishq,ska jeks j¾Ol øjH - 1 ^IGF-1& iy tys iuldrl
( fupdfkda j¾Ol øjH ^MGFs& ( maf,Ü,Ü-ärhsÉâ j¾Ol øjH ^PDGF& ( ;hsfudaiSka - 4 iy tys iuldrl ( Wod' ( TB-500
jeialshq,¾ -tkafvdf;,sh,a j¾Ol øjH ^VEGF& iy fmaYS" lKavrd fyda wiaÓ nkaOkh" fm%daàka ixiaf,aIKh$wjl%uKh"
reêr jykh we;s lsÍu" Yla;sh Wmfhda.SlrKh" m%;sckk yelshdj fyda ;ka;= iajNdjfha wm.ukh flfrys n,mdk fjk;a
hï j¾Ol øjHhka'
S3' îgd-2 we.ksiaÜ
  my; i|yka ldrl we;=<;a úh hq;= kuq;a" tAjdg iSud fkdúh hq;= hs'
f*fkdfgfrda,a ( f*dafudfgfrda,a ( yhscekñka ( bkavlegfrd,a ( Tf,dvegfrda,a ( fm%dlegfrda,a ( frfm%dgefrd,a ( ie,aìhqgfuda,a (
ie,auegfrda,a ( g¾ìhqge,ska ( á%fgdl=hsfkda,a ^g%hsfufgdl=hsfkd,a& ( áhqf,dìhqfgfrda,a ( ú,ekafgfrda,a
 ie,aìhqgfuda,a ^uhsfl%d.%Eï 1600 l Wmßuhla meh 24 la ;=<" fjka lr.;a ud;%djka f,i iEu meh 12 l§u ´kEu
 ud;%djlska wdrïN lr uhsfl%d.%Eï 800 iSudj fkdblaujd& bkafya,rhlska ,nd .kakd úg (
 f*da¾ufgfrda,a ^meh 24 la ;=< uhsfl%d.%Eï 54l Wmßu ud;%djla& bkafya,rhlska ,nd .kakd úg
 ie,afugfrda,a meh 24 lg jeä ld,hla ;=< uhsfl%d.%Eï 200 l Wmßuhla bkafya,rhlska ,nd .kakd úg yer
 wod< jk wjia:djl § ish¨u f;dard .;a iy f;dard fkd.;a îgd - 2 we.ksiaáia" we;=¿j Tmaál,a whsfidau¾ ish¨u ;ykï
fõ'
uq;%dj, ie,aìhqgfuda,a 1000 ng$ML g jeäfhka fyda f*da¾ufgfrda,a 40 ng$ML g jeäfhka mj;skafka hhs wkqudk lsÍfï§
Ñls;ail Ndú; øjHhka woyia lsÍula fkdúh hq;= w;r ta widudkH m%;sM,h" by; olajd we;s Ñls;ail ud;%dj bkafya,rhla
u.ska" Wmßu ud;%djla olajd Ndú;d lsÍfï m%;sM,hla f,i we;s jQ njg md,kh lrk ,o T!IO wjfYdaIkh jk yd .uka
lrk wdldrh ms<sn| wOHhkhla ud¾.fhka l%Svlhd úiska Tmamq lr we;akï ñi" wys;lr úYaf,aIKd;aul jd¾;djla
^Adverse Analytical Finding& f,i i,lkq ,eìh yelsh'
S4' fyda¾fudak iy mßjD;a;Sh fudähqf,ag¾
my; oelafjk fyda¾fudak iy mßjD;a;Sh fudähqf,ag¾ ;ykï lr we;'
1' wefrdaudfÜia ksfYaOl we;=<;a úh hq;= kuq;a" my; øjHhkag iSud fkdúh hq;=h'
2- wekafv%diaáfkda,a ^5androst-2-en-17ol& ; 2- wekafv%daisáfkdaka ^5androst-2-en-17one& (
3' wekafv%diaáfkda,a ^5androst-3-en-17ol& ; 3- wekafv%disáfkdaka ^5androst-3-en-17one& ( weñfkda.a¨f;;suhsâ (
wekiafg%dfida,a ( wekafv%diagd -1, 4,6-triene-3,17-dione ^wekafv%diagdg%hstksäfhdaka& ( wekafv%diagd -3,5-diene-7, 17-dione
^weßñiafÜka& ( 4-wekafv%diaàka - 3,6,17 trione (6-oxo) : tlaisfuiafÜka ( f*da¾fuiafÜka ( f,fg%dfida,a iy fgiafgd,elafgdaka'
2' jrKSh Biag%cka .%dyl fudähqf,ag¾ ^SERMs& we;=<;a úh hq;= kuq;a" my; øjHhkag iSud fkdúh hq;=h ( /f,daiais*ska"
gefudlaisf*ka iy fgdfrñ*Ska'
3' fjk;a m%;s-Biag%cksl øjH we;=<;a úh hq;= kuq;a my; øjHhkag iSud fkdúh hq;=h' ( laf,dañ*ska ( ihslaf,df*kS,a iy
*q,afjiag%kaÜ
4' welaáúka m%;s.%dyl  ys l%shdldß;ajh je,elaùu i|yd Þhl jk ldrl we;=<;a úh hq;= kuq;a my; øjHhkag iSud fkdúh
hq;=hs' welaáúka A - WodiSk lsÍfï m%;s foay (
äfldhs welaáúka m%;s.%dyl ^Wod' ACE-031& ( m%;s-welaáúka IIB m%;sfoay ^Wod' ìud.Dueí& jeks welaáúka IIB ys ;r.ldÍ øjHhka (
ufhdiageáka m%ldYkh wju lrk fyda bj;a lrk ldrl ( ufhdiageáka nkaOk fm%daàk ^f*,siageáka fm%dfmmaghsâ& (
ufhdiageáka - WodiSk lsÍfï m%;sfoay ^Wod ( fvdue.afrdiqueí" ,ekafvd.afrdiqueí iageuq¨ueí& jeks ufhdiageúka ksfYaOl'

<!-- page 5 -->

I fldgi: (I) fPoh - Y%S ,xld m%cd;dka;%sl iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h -  2019'02'11 5 A
5' mßjD;a;Sh fudähqf,ag¾
 5'1 AMP  welaáfõgâ fm%daàka lhsfkaia il%Sh ldrlh ^AMPK& Wod' AICAR; SR9009 iy fmfrdlaisfidaï fm%d,s*f¾g¾
welaáfõgâ ßfimag¾^PPAR & we.aksiaÜia" Wod' 2-(2methyl -4-(4-,,methyl-2-(4-trifluoromethyl)phenyl)thiazol-5-yl) methylthio)
phenoxy) aceticacid(GW 1516, GW501516) ;
 5'2 bkaishq,skaia iy bkaishq,ska - wkqldrl;
 5'3 fu,aafvdakshï ;
 5'4 g%hsfugisãka ;
S5' uQ;%dldrl T!IO iy fjk;a m%;sÉPdok ldrl
my; oelafjk uQ;%dldrl yd m%;sÉPdok ldrl ;ykï fõ' ta yd iudk ridhksl jHqyhla fyda iudk Ôj úoHd;aul
n,mEula ^n,mEï& we;s fjk;a øjHhka we;=<;a úh hq;= kuq;a" my; øjHhkag iSud fkdúh hq;=h'
fviafudfm%iska ( fm%dafnksisâ ( ma,diaud m%idrl Wod' wka;¾Ysrd u.ska tkak;a lrk ,o we,aìhqñka" fvlaiag%ka"
yhsfv%dlaist;s,a iagd^¾&É iy ueksfgd,a'
weisgfid,uhsâ ( weñf,drhsâ ( ìhqfugkhsâ ( lekaßfkdaka ( laf,da¾g,sfvdaka ( tgl%sksla wï,h ( *Hqfrdfiuhsâ (
bkavmuhsâ ( fufgd,fidaka ( iamsfrdfkda,elafgdaka ( ;hihsâ ( Wod' fnkafv%d*aÆñ;hihsâ ( laf,dafrda;hihsâ
iy yhsfv%dlaf,dafrda;hihsâ ( g%hïfgßka iy jemagkaia Wod' fgd,ajemagka
my; oelafjk foaj,a yer (
fv%diamsrfkdaka ( meufn%dï ( iy ldnka iys; ks¾c,Sh ksfIaOlj, wlaIsuh Ndú;h Wod( fvda¾fid,uhsâ iy
ì%kafid,uhsâ'
oka; ks¾úkaokfha § fhdod.kakd f*,sfm%iSka ia:dkSh Ndú;h
ish¿u wjia:djka ys § fyda ;r. ;=< § hï l%svlfhl=f.a uQ;%d idïm,hl foay,Sh iSudjg wod, jk mßÈ my; oelafjk øjH
´kEu m%udKhla ( f*da¾ufgfrd,a ( ie,aìhqgfuda,a ( le;Ska ( t*sã%ka ( ó;hs,at*sã%ka" iy isjqfvdf*ã%ka uQ;%ldrl fyda
m%;sÉPdok ldrl iu. ixhqla; ù we;s nj wkdjrKh jQ úg" l%Svlhd i;=j wjirh ,eî we;s uQ;%ldrl yd                 m%;sÉPdok
ldrlj,g wu;rj fjk;a øjHhla fjkqfjka wkqu; fN!;sl Ñls;ail úks¾uqla;s (Therapeutic Use Exemption-TUE) f,aLkhla
fkdue;s kï th —wys;lr úYaf,aIKd;aul fidhd.ekSula˜  ^Adverse Analytical Finding- AAF& fõ'
;ykï l%u
M1' reêrh iy reêr ix>gl yeisrùu
my; oelafjk foaj,a ;ykï lr we;(-
01' Tfgdaf,da.ia" wef,dafcksla ^fydafudaf,da.ia& fyda fygfrdf,da.ia reêrh fyda ´kEu m%Njhl r;= reêrdKq ffi, ´kEu
m%udKhla reêr ixirK moaO;shg kej; y÷kajd §u fyda mßmd,kh lsÍu 

02' Tlaiscka ,nd .ekSu" m%jdykh yd fnodyeÍu lD;%suj jeä lrk oE we;=<;a úh hq;= kuq;a bkafya,rhlska .kakd
w;sf¾l Tlaiscka yer my; øjHhkaj,g iSud fkdúh hq;=h (-
m¾*a¨Tfrdaflñl,aia" t*fm%dlaisr,a ^RSR 13& iy kùlrKh lrk ,o ysfud.af,dìka ksIamdolhka ^
Wod' ysfud.af,dìka
mokï jQ reêr wdfoaYl ( iy uhsfl%dtkalemaishqf,agâ ysfud.af,dìka ksIamdok&
03' fN!;sl fyda ridhksl jYfhka reêrh fyda reêr ix>gl ´kEu wdldrhlska wka;¾jdyskS ;=<g yeisrùu'

<!-- page 6 -->

6  A I  fldgi: (I) fPoh - Y%S ,xld m%cd;dka;%sl iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2019'02'11
M2' ridhksl yd fN!;sl yeisrùu
my; oelafjk foaj,a ;ykï lr we;'
01' W;af;acl md,kh isÿlrkq ,nk ld, iSudj ;=< § tl;= lrk ,o idïm,j, iajNdjh iy j,x.=Ndjh fjkia lsÍu fyda
fjkia lsÍug m%h;ak oeÍu ;ykï lr we;' uQ;%dj,g wdfoaYk iy$fyda l,jï lsÍï ^
Wod' fm%daàiia& fïjdfha we;=<;a úh hq;=
kuq;a Bg iSud fkdúh hq;= h'
02' frday,g we;=<;a jk wjia:djl §" Y,Hl¾u l%shd mámdáhl § fyda idhksl mÍlaIK wjia:djl § ,enqKq kS;Hkql+,
foaj,a yer meh fod<yl ^12& ld, iSudjla i|yd jQ 100 MLlg jeä wka;¾Ysrd idrh iy$fyda kslafIamK'
M3' cdk yd ffi,uh Woa§mk ldrl
01' kshqla,sla wï,h fyda kshqla,slaa wï,fha nyq wjhjlj, wkqms<sfj, udre lsÍu'
02' cdk wkqms<sfj, yd$fyda cdkuh m%ldYkfha msgm;a lsÍu yd Ñls;ail kshdukh fjkia lsÍu i|yd ks¾udK lrk ,o
    ix>gl'
02' idudkH fyda cdkuh jYfhka fjkia l< ffi, Ndú; lsÍu'
;r. ;=< § ;ykï lrk ,o øjHhka yd l%u
by; úia;r lrk ,o S0 isg  S5 iy M1 isg M3 olajd jQ m%fNaoj,g wu;rj ;r. ;=< § my; oelafjk m%fNaohka ,nd
.ekSu ;ykï fõ'
;ykï lrk ,o øjHhka
S6' W;af;acl
ish¿ Tmaál,a whsfidau¾ia we;=¿j ^
Wod' d- iy l-& ish¨u W;af;acl wod, jk úg ;ykï fõ'
W;af;aclj, we;=<;a lsÍï (
w' úfYaIfhka i|yka fkdlrk ,o W;af;acl (
weâr*sks,a ( weïf*m%dfudaka ( weïf*guhska ( weïf*gñks,a ( weïf*kfida,a ( fnka*a¨fjdfrlaia ( fnkaihs,amsmriska (
fn%duekagka ( laf,dfnkafidfrlaia ( fldflaka ( fl%dfm%dmuhsâ ( fl%dfgguhsâ ( f*kaleuhska ( f*ksghs,ska ( f*ka*a¨rduhska (
f*kafm%dfmdfrlaia ( f*dkafgrflgï [4-phenylpiracetam (carphedon)] ( *¾f*fkdfrlaia ( ,siafvlaieñf*guhska" fu*fkdfrlaia
( fu*kag¾uhska ( fufidldí ( fugïf*guhska ^d-& ;p-ó;hs,aweñf*guhska ( fudv*skS,a ( fkda¾f*ka*aÆruhska ( f*kaäfug%iska
( f*kag¾uhska ( fm%ks,uhska ( fm%d,skafÜka'
fuu ,ehsia;=j ;=< m%ldYs;j ,ehsia;=.; lr fkdue;s W;af;aclhla úfYaIfhka i|yka lrk ,o øjHhla fõ'
wd' úfYaIfhka i|yka lrk ,o W;af;acl
my; i|yka øjH we;=<;a úh hq;= kuq;a tajdg iSud fkdúh hq;=h (
3-fu;s,afylaika-2-weóka ^1,2-dimethylpentylamine& 4-fu;s,afylaika - 2 - weóka ^ó;hs,a fylaiekuhska& ( 4-fu;s,afmkagka-
2-weñka ^1,3-dimethylpentylamine& ( 5-fu;s,fylaika - 2 - weñka ^1"4dimethylpentylamine& ( fnkaiaf*guhska; le;Ska **;
le;sfkdka iy tys iuldrl Wod' fu*sfv%dka ( fu;sfv%dka iy 
-msr,svhsfkdj,frd*sfkdka ( vhsfugdweïf*guhska (
^vhsfu;s,aweïfkguhska (t*sã%ka& *** : t*sfk*%ska **** ^weä%k,ska& ( tgñjka ( tá,aweïf*guhska ( tÜf,*%ska ( *eïfm%d*fidaka
( f*kaìhqg%fiaÜ ( f*kaleïf*ñka ( fymagñfkda,a ( yhsfv%dlaisweïf*guhska ^merdyhsfv%dlaisweïf*guhska& whsfidafu;smaáka (
f,õfuÜweïf*guhska : fulaf,daf*fkdlafiaÜ ( ó;hs,atksäfhdlaisfu;ïf*guhska ( ó;hs,at*sä%ka ***; ó;hs,af*ksfâÜ (
ksfl;uhsâ ( fkda¾f*ks*%hska ( Tlafgdmeuhska ( Tlaisf,d*%Ska ^ñ;hs,aisfk*%Ska& ( fmfud,ska ( fmkafgg%dfida,a ( f*ks;s,aweuhska
iy tajdhska m%Njh ,;a oE ( f*kafug%iSka ( f*kafm%dfu;uhska ( fm%dms,afylaisã%ka ( isjqfvdt*sã%ka ***** : fi,sÔ,Ska ( isnqg%duhska
( iag%hsÑkska ( fgkïf*guhska ^fu;s,Skaäfhdalaisweïf*guhska& ( gqjñfkdfymafÜka ( iy iudk ridhksl jHqyhla fyda iudk Ôj
úoHd;aul n,mEula ^n,mEï& we;s fjk;a øjHhka'

<!-- page 7 -->

I fldgi: (I) fPoh - Y%S ,xld m%cd;dka;%sl iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h -  2019'02'11 7 A
my; oelafjk øjHhka yer (
laf,dksvhska
iu u;=msg .e,aùu i|yd fyda wefiys .e,aùu i|yd jk bñvfida,a j,ska m%Njh ,;a oE iy 2019 wëlaIK jevigyfka
we;=<;a ù we;s tu W;af;acl'
  * nhqfm%dmsfhdaka" lef*aka" ksfldàka" *skhs,at*%Ska" *skhs,afm%dmfkd,aweuhska" msm%fvda,a iy isfk*%Ska (
fuu øjH 2019 wëlaIK jevigykg we;=<;a lr we;s w;r ;ykï lrk ,o øjHhka jYfhka fkdie,fla'
  ** le;Ska ( uq;%dj, le;Ska idkaøKh ñ,s ,Sgrhg uhsfl%d.%Eï 5 g jvd jeä jk úg ;ykï fõ'
  *** t*sã%ka iy ó;hs,at*%Sã%ka ( uq;%dj, t*Sã%ka fyda ó;hs,a t*%Sã%ka idkaøKh ñ,s ,Sgrhg uhsfl%d.%Eï 10 g jeä jk úg
;ykï fõ'
  **** tmsfk*%Ska ^weã%k,Ska& ( ia:dkSh f,i ,nd .ekSu ^Wod' kdih" wlaIsfõoh& fyda ia:dkSh ks¾úkaok ldrlhka iu. iu
jYfhka fhdod .ekSu ;ykï fkdfõ'
  ***** isjqfvdat*sã%ka ( uq;%dj, tys idkaøKh ñ,s ,Sgrhg uhsfl%d.%Eï 150 g jeä jk úg ;ykï fõ'
S7' udol
;ykï jQ
ìhqm%sfkda¾*Ska ( fvlaiafg%dfudruhsâ ( vhfuda¾*Ska ^fyfrdhska & ( f*kagks,a iy tajdfha m%Njh,;a øjHhka ( yhsfv%dfuda¾f*daka (
fu;fvdaka ( fuda¾*Ska ( ksfldfuda¾*Ska ( Tlaisfldafvdaka ( Tlaisfuda¾f*daka ( fmkagfidihska iy fm;sãka'
S8' lekìfkdhsâia lxid$.xcd
;ykï jQ
 iajNdúl ^Wod' lxid$.xcd" yISia iy ußcqjdkd&
 iska;ála lekìfkdhsâia ^Wod'   9 - fgg%dyhsfv%dlekìfkda,a ^THC& iy fjk;a lekìuhsueálaia"
my; i|yka øjH yer
 lekìvhsT,a
S9' .a¨fldflda¾áfldhsâia
uqL" wka;¾Ysrd" wka;¾fmaYs fyda .=o ud¾.fhka .kq ,nk úg ish¨u .a¨fldflda¾áfldhsâia ;ykï fõ'
my; i|yka øjH we;=<;a úh hq;= kuq;a tAjdg iSud fkdúh hq;= h'
ìgdfu;fidaka (
ìhqÜfidkhsÜ (
fldaáfidaka (
fv*a,didfldaÜ (
fvlaidfu;fidaka(
*q¨áldfidaka (
yhsfv%dfldáfidaka (
fu;s,afm%âksif,daka (
fm%âksif,daka (
fm%âksfidaka (
g%hsheïisfkdf,daka'

<!-- page 8 -->

8  A I  fldgi: (I) fPoh - Y%S ,xld m%cd;dka;%sl iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2019'02'11
úfYaIs; l%Svd j,§ ;ykï l< øjHhka
P1' îgd íf,dl¾ia
my; oelafjk l%Svd j, §" ;r. ;=< § ^ In-Competition& muKla îgd íf,dl¾ia ;ykï lr we;s w;r" my; olajd we;s
wjia:djkays § ;r.fhka msg; § mjd îgd íf,dl¾ia ;ykï fõ'
ÿkq Ys,amh ^WA&
fudag¾ r: Odjk ;r. ^FIA&
ì,shâia - ^ish¿ ;r. j, § ^WCBS&
vdÜia l%Svdfõ § ^WDF&
f.d,a*a l%Svdfõ § ^IGF&
b,lalhg fjä ;eîfï § ^ISSF, IPC&
ysu u; ,siaid hdu$ysu mqjre ;rKh ^FIS&$Wod ( ysu u; mekSu ^Jumping&" ksoyia wdr lrKï$yd*a mhsma ^halfpipe&
iy ysu mqjre yd*a mhsma ^halfpipe& $ì.a thd¾ ^big air&
Èh hg isÿ lrk l%Svd ^CMAS&" jr,a iys; fyda rys; ia:dhs-nr ffkrdkh" jr,a iys; fyda rys; .;sl ffkrdkh"
ksoyia .s,aùï ffkrdkh" ks,a meye;s msñ ffkrdkh" iamsh¾*sIska" iaÓ;sl ffkrdkh" b,lalhg úÈk iy fjkiajk
iq¿ nr ffkrdkh'
 * ;r.fhka msg; § o ;ykï fõ'
îgd íf,dl¾ia o we;=,;a jk kuq;a" my; ±lafjk tAjdg iSud fkdúh hq;=h'
tisìhqgf,da,a ( we,am%sfkdf,da,a ( wfgfkdf,d,a ( fngelafidf,d,a ( ìfidfm%df,da,a ( ìhqfkdf,da,a ( ldáfhdf,d,a (
ldfjäf,da,a ( fi,sfm%df,da,a ( tiauf,d,a ( ,eîgf,d,a ( fuám%ekf,da,a ( fufgdfm%df,da,a ( kevf,da,a ( Tlaiam%sfkdf,d,a (
mskafvdf,d,a ( fm%dm%efkdf,d,a ( fidgef,d,a iy áuf,d,a'
2019 wëlaIK jevigyk
my; i|yka øjH wëlaIK jevigykg we;=<;a lr we;'
1' W;af;acl ( ;r. ;=< § ^ In-Competition & muKla ( ìhqfm%dmsfhdaka" lef*aka" ksfldàka" *skhs,at*%Ska"
*skhs,afm%dmfkd,aweuhska" msm%fvda,a iy isfk*%Ska'
2' udol ( ;r. ;=< § ^ In-Competition& muKla ( fldaãka" yhsfv%dfldafvdaka iy Ü/ufvda,a
3' .a¨fldflda¾áfldhsâia ( ;r. ;=< § ^In-Competition& ^uqL" wka;¾Ysrd" wka;¾fmaYS fyda .=o ud¾.fhka .kq ,nk
.a¨fldflda¾áfldhsâia yer fjk;a m%fNaohka& yd bka msg;§ ^Out - of -Competition& ^.kq ,nk ish¿u ud¾.&
4' 2-ethylsulfanyl-1H-benzimidazole(bemitil) ( ;r. j,§ yd bka msg; § ( ^In Competition and Out - of - Competition&
5' îgd-2 we.ksiaÜ ( ;r. j,§ yd bka msg § ^ In-Competition and out-of-Competition& ( îgd-2 we.ksiaÜ ys ´kEu
ixfhdackhla we;=<;a fõ'
02 - 354
Y%S ,xld rcfha uqøK fomd¾;fïka;=fõ uqøKh lrk ,§'